STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

March 8, 2023

Period of Report

March 6, 2023

Accession Number

0001062993-23-006333